title: Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: new associations?
authors.forename: A K
authors.initials: AK
authors.lastname: Bag
authors.forename: J K
authors.initials: JK
authors.lastname: Curé
authors.forename: J C
authors.initials: JC
authors.lastname: Sullivan
authors.forename: G H
authors.initials: GH
authors.lastname: Roberson
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use; D054038:Posterior Leukoencephalopathy Syndrome / Q000209:etiology* / Q000503:physiopathology; D055815:Young Adult
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D006886:Hydroxychloroquine; D015122:Mercaptopurine